NRX Pharmaceuticals (NRXP) closed at $2.36 on November 10, 2026, down 0.8% from the previous close, on volume of 476,385 shares (30-day average 1,358,312).
Data as of November 10, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 10, 2026. See the 10 largest for 30, 60 and 90 days
NRx Pharmaceuticals Begins Selling U.S.-Made, Preservative-Free Ketamine Amid Long-Running Shortage
Globe Newswire (Wed, 11-Nov 7:00 AM ET)
NRX Pharmaceuticals (NRXP) Receives a Buy from H.C. Wainwright
TipRanks (Mon, 9-Nov 6:35 AM ET)
Globe Newswire (Fri, 30-Oct 7:00 AM ET)
Globe Newswire (Thu, 29-Oct 4:00 PM ET)
Globe Newswire (Mon, 19-Oct 8:30 AM ET)
NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine
Globe Newswire (Thu, 15-Oct 8:27 AM ET)
Globe Newswire (Wed, 30-Sep 7:00 AM ET)
Globe Newswire (Tue, 15-Sep 3:11 PM ET)
Globe Newswire (Mon, 14-Sep 7:00 AM ET)
Globe Newswire (Fri, 11-Sep 7:00 AM ET)
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
NRX Pharmaceuticals trades on the NASDAQ stock market under the symbol NRXP.
As of November 11, 2026, NRXP stock price climbed to $2.44 with 748,283 million shares trading.
NRXP has a beta of 1.87, meaning it tends to be more sensitive to market movements. NRXP has a correlation of 0.10 to the broad based SPY ETF.
NRXP has a market cap of $105.64 million. This is considered a Micro Cap stock.
Last quarter NRX Pharmaceuticals reported $1 million in Revenue and -$.44 earnings per share. This fell short of revenue expectation by $-442,736 and missed earnings estimates by -$.32.
In the last 3 years, NRXP traded as high as $7.33 and as low as $1.10.
The top ETF exchange traded funds that NRXP belongs to (by Net Assets): VTI, PSIL, VXF, IWC.
NRXP has underperformed the market in the last year with a price return of -3.9% while the SPY ETF gained +12.7%. NRXP has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -27.2% and -9.3%, respectively, while the SPY returned -1.4% and -1.2%, respectively.
NRXP support price is $2.22 and resistance is $2.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NRXP shares will trade within this expected range on the day.
